首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1698491

口服給藥市場：未來預測（2025-2030）

Oral Drug Delivery Market - Forecasts from 2025 to 2030

出版日期: 2025年03月19日 | 出版商:

Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

口服給藥市場預計將從 2025 年的 1,339.44 億美元成長到 2030 年的 1,695.86 億美元，複合年成長率為 4.83%。

口服給藥被認為是最常見的給藥方法，因為它是非侵入性的，患者遵從率高，易於操作，不需要特殊的無菌條件。因此受到廣大患者的歡迎。由於世界各地慢性病的流行，這種藥物輸送方法的需求量很大。此外，研發投資的增加、醫療保健支出的增加以及人口老化可能會促進整個預測期內的市場擴張。

市場趨勢：

慢性病流行：全球慢性病的快速增加，對口服給藥市場的擴張起了很大的推動作用。此方法為心血管疾病、癌症、糖尿病等患者提供了一種無痛、便捷的給藥方式。另一個好處是它減少了監測的需要並降低了醫療成本。尤其是全球糖尿病的盛行率正在急劇上升，英國糖尿病協會報告稱，預計2022-23年間，光是英國就將出現440萬例糖尿病病例，這凸顯了對有效口服給藥解決方案的需求日益成長。
增加研發投資：藥物輸送技術的進步加上製藥業活性化的研發投資是市場成長的關鍵驅動力。
北美市場的主導地位：由於技術創新、專利核准的增加以及奈米技術在藥物傳輸應用方面的開創性研究，北美有望佔據口服藥物傳輸市場的很大一部分。特別是，美國預計將佔據相當大的市場佔有率，因為它是尖端藥物輸送技術的早期採用者，並且在整個預測期內其研究中心都致力於開發新的口服藥物輸送系統。

報告中介紹的主要企業包括輝瑞、Astra Zeneca、Alpex Pharma SA、SPI Pharma、Globela Pharma Pvt Ltd.、Lupin Pharmaceuticals, Inc.、Mayne Pharma Group Limited、Adare Pharmaceuticals, Inc.、AdhexPharma、Aquestive Therapeutics、RAUMEDIC 和 Croda International Plc。

本報告的主要優點

深刻分析：獲得涵蓋主要地區和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
競爭格局：了解全球主要企業採取的策略策略，並了解正確策略帶來的潛在市場滲透。
市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
適用範圍廣：對於新興企業、研究機構、顧問公司、中小企業和大型企業來說，它都是實用且具有成本效益的。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024）和預測資料（2025-2030）
成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
競爭對手定位、策略和市場佔有率分析
按部門和地區（國家）分類的收益成長和預測分析
公司概況（策略、產品、財務資訊、主要趨勢等）

口服給藥市場細分：

按劑型

錠劑
膠囊
降低
粉末
液體/糖漿
湯

按應用

疾病治療
研究和學術目的

按地區

北美洲
歐洲
亞太地區
南美洲
中東和非洲

Oral drug delivery is non-invasive, has a high rate of patient compliance, is easy to handle, and does not require any special sterile conditions; it is considered the most popular method of administration. Hence, it is highly preferred by a wide spectrum of patients. This drug delivery method is in high demand because of the prevalence of chronic diseases worldwide. Moreover, rising research and development investment, advancing health expenditure, and an aging population will all contribute to market expansion throughout the projection period.

Market Trends:

Rise in Chronic Disease Prevalence: The global surge in chronic illnesses significantly contributes to the expansion of the oral drug delivery market. This method provides a painless and convenient option for administering medication to patients with conditions such as cardiovascular diseases, cancer, and diabetes. It also benefits from reduced oversight requirements and lower care costs. Notably, the prevalence of diabetes has spiked globally, with Diabetes UK reporting a total of 4.4 million cases in the UK alone during 2022-23, underscoring the growing demand for effective oral drug delivery solutions.
Increased Investment in Research and Development: Advancements in drug delivery technologies, coupled with heightened R&D investments within the pharmaceutical industry, are pivotal in driving market growth.
North America's Market Dominance: North America is poised to capture a substantial portion of the oral drug delivery market, fueled by technological innovations, an increase in patent approvals, and pioneering research into nanotechnology applications for drug delivery. The United States, in particular, is anticipated to command a significant market share, thanks to its quick uptake of cutting-edge drug delivery technologies and the presence of research hubs focused on developing novel oral drug delivery systems throughout the forecast period.

Some of the major players covered in this report include Pfizer Inc., AstraZeneca, Alpex Pharma S.A., SPI Pharma, Globela Pharma Pvt Ltd., Lupin Pharmaceuticals, Inc., Mayne Pharma Group Limited, Adare Pharmaceuticals, Inc., AdhexPharma, Aquestive Therapeutics, RAUMEDIC, and Croda International Plc, among others.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Oral Drug Delivery Market Segmentation:

By Formulation

Tablets
Capsules
Drops
Powder
Liquid or Syrup
Decoction

By Application

Disease Treatment
Research/Academic purposes

By Region

North America
Europe
Asia Pacific
South America
Middle East & Africa

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ORAL DRUG DELIVERY MARKET BY FORMULATION

5.1. Introduction
5.2. Tablets
5.3. Capsules
5.4. Drops
5.5. Powder
5.6. Liquid or Syrup
5.7. Decoction

6. ORAL DRUG DELIVERY MARKET BY APPLICATION

6.1. Introduction
6.2. Disease Treatment
6.3. Research/Academic purposes

7. ORAL DRUG DELIVERY MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. By Formulation
- 7.2.2. By Application
- 7.2.3. By Country
  - 7.2.3.1. USA
  - 7.2.3.2. Canada
  - 7.2.3.3. Mexico
7.3. South America
- 7.3.1. By Formulation
- 7.3.2. By Application
- 7.3.3. By Country
  - 7.3.3.1. Brazil
  - 7.3.3.2. Argentina
  - 7.3.3.3. Others
7.4. Europe
- 7.4.1. By Formulation
- 7.4.2. By Application
- 7.4.3. By Country
  - 7.4.3.1. United Kingdom
  - 7.4.3.2. Germany
  - 7.4.3.3. France
  - 7.4.3.4. Spain
  - 7.4.3.5. Others
7.5. Middle East and Africa
- 7.5.1. By Formulation
- 7.5.2. By Application
- 7.5.3. By Country
  - 7.5.3.1. Saudi Arabia
  - 7.5.3.2. UAE
  - 7.5.3.3. Others
7.6. Asia Pacific
- 7.6.1. By Formulation
- 7.6.2. By Application
- 7.6.3. By Country
  - 7.6.3.1. China
  - 7.6.3.2. Japan
  - 7.6.3.3. India
  - 7.6.3.4. South Korea
  - 7.6.3.5. Taiwan
  - 7.6.3.6. Others